Acquisition by Diaz-mitoma Francisco of 40000 shares of VBI Vaccines at 0.5 subject to Rule 16b-3
Slightly above 67% of VBI Vaccines' investor base is looking to short. The analysis of current outlook of investing in VBI Vaccines suggests that many traders are alarmed regarding VBI Vaccines' prospects. VBI Vaccines' investing sentiment can be driven by a variety of factors including economic data, VBI Vaccines' earnings reports, geopolitical events, and overall market trends.
VBI |
Filed transaction by VBI Vaccines Officer Chief Medical Officer. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
VBI Vaccines Fundamental Analysis
We analyze VBI Vaccines' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of VBI Vaccines using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of VBI Vaccines based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
VBI Vaccines is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
VBI Vaccines Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with VBI Vaccines stock to make a market-neutral strategy. Peer analysis of VBI Vaccines could also be used in its relative valuation, which is a method of valuing VBI Vaccines by comparing valuation metrics with similar companies.
Peers
VBI Vaccines Related Equities
ANVS | Annovis Bio | 12.33 | ||||
ALLO | Allogene Therapeutics | 7.18 | ||||
JAGX | Jaguar Animal | 5.10 | ||||
BBIO | BridgeBio Pharma | 4.83 | ||||
IBIO | Ibio | 2.54 | ||||
GOVX | GeoVax Labs | 2.26 | ||||
VXRT | Vaxart | 1.67 | ||||
ARDX | Ardelyx | 1.31 | ||||
AKRO | Akero Therapeutics | 0.67 | ||||
AUPH | Aurinia Pharmaceuticals | 0.34 | ||||
TNXP | Tonix Pharmaceuticals | 2.50 | ||||
OCGN | Ocugen | 2.70 | ||||
ANIX | Anixa Biosciences | 4.09 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in VBI Stock
If you are still planning to invest in VBI Vaccines check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the VBI Vaccines' history and understand the potential risks before investing.
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |